Literature DB >> 24588559

Cannabinoids: clearing the smoke on pain, inflammation and neurodegeneration.

E J Downer1, D P Finn.   

Abstract

LINKED ARTICLES: This article is part of a themed section on Cannabinoids 2013. To view the other articles in this section, see Fagan and Campbell (2014) DOI: 10.1111/bph.12492, Ignatowska-Jankowska et al. (2014) DOI: 10.1111/bph.12298, Ligresti et al. (2014) DOI: 10.1111/bph.12410, Lopez-Rodriguez et al. (2014) DOI: 10.1111/bph.12519, Murataeva et al. (2014) DOI: 10.1111/bph.12411, Okine et al. (2014) DOI: 10.1111/bph.12540, Rodríguez-Cueto et al. (2014) DOI: 10.1111/bph.12283, Stanley and O'Sullivan (2014) DOI: 10.1111/bph.12560, Toguri et al. (2014) DOI: 10.1111/bph.12545, Wu et al. (2014) DOI: 10.1111/bph.12500. Linked articles are: Avraham et al. (2014) DOI: 10.1111/bph.12478, Machado et al. (2014) DOI: 10.1111/bph.12488, Ward et al. (2014) DOI: 10.1111/bph.12439.
© 2014 The British Pharmacological Society.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24588559      PMCID： PMC3954475          DOI： 10.1111/bph.12642

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  15 in total

Review 1.  The influence of cannabinoids on generic traits of neurodegeneration.

Authors:  S G Fagan; V A Campbell
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias.

Authors:  Carmen Rodríguez-Cueto; Cristina Benito; Javier Fernández-Ruiz; Julián Romero; Mariluz Hernández-Gálvez; María Gómez-Ruiz
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.

Authors:  Sara Jane Ward; Sean D McAllister; Rumi Kawamura; Ryuchi Murase; Harshini Neelakantan; Ellen A Walker
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine.

Authors:  F C Machado; V O Zambelli; A C O Fernandes; A S Heimann; Y Cury; G Picolo
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition.

Authors:  Alessia Ligresti; Jose Martos; Jenny Wang; Francesca Guida; Marco Allarà; Vittoria Palmieri; Livio Luongo; David Woodward; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS.

Authors:  N Murataeva; A Straiker; K Mackie
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Long-term consequences of perinatal fatty acid amino hydrolase inhibition.

Authors:  Chia-Shan Wu; Daniel Morgan; Chris P Jew; Chris Haskins; Mary-Jeanette Andrews; Emma Leishman; Corinne M Spencer; Traci Czyzyk; Heather Bradshaw; Ken Mackie; Hui-Chen Lu
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.

Authors:  Hava Karsenty Avraham; Shuxian Jiang; Yigong Fu; Edward Rockenstein; Alexandros Makriyannis; Alexander Zvonok; Eliezer Masliah; Shalom Avraham
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.

Authors:  B M Ignatowska-Jankowska; S Ghosh; M S Crowe; S G Kinsey; M J Niphakis; R A Abdullah; Q Tao; S T O' Neal; D M Walentiny; J L Wiley; B F Cravatt; A H Lichtman
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

10.  The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.

Authors:  Liting Deng; Josée Guindon; V Kiran Vemuri; Ganesh A Thakur; Fletcher A White; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Mol Pain       Date:  2012-09-22       Impact factor: 3.395
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.